Joana Caetano

ORCID: 0000-0001-7509-9066
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Myeloma Research and Treatments
  • Chemokine receptors and signaling
  • Extracellular vesicles in disease
  • Vascular Malformations Diagnosis and Treatment
  • Protein Degradation and Inhibitors
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Infectious Diseases and Tuberculosis
  • Hematopoietic Stem Cell Transplantation
  • Immunotherapy and Immune Responses
  • Head and Neck Surgical Oncology
  • Hepatitis B Virus Studies
  • Helicobacter pylori-related gastroenterology studies
  • Hematological disorders and diagnostics
  • Cancer Genomics and Diagnostics
  • Blood transfusion and management
  • Single-cell and spatial transcriptomics
  • Sarcoidosis and Beryllium Toxicity Research
  • Systemic Sclerosis and Related Diseases
  • Digital Imaging for Blood Diseases
  • Renal Transplantation Outcomes and Treatments
  • Nutrition and Health in Aging
  • Healthcare Systems and Reforms
  • Childhood Cancer Survivors' Quality of Life
  • IgG4-Related and Inflammatory Diseases
  • Viral-associated cancers and disorders

Champalimaud Foundation
2020-2024

Hospital Prof. Dr. Fernando Fonseca
2024

Universidade Nova de Lisboa
1990-2024

Nova Medical (United States)
2022

University of Coimbra
2021

Instituto Português de Oncologia Francisco Gentil
2014-2020

University of Geneva
2013

Instituto Português de Oncologia de Coimbra Francisco Gentil
2008

Flow cytometry has become a highly valuable method to monitor minimal residual disease (MRD) and evaluate the depth of complete response (CR) in bone marrow (BM) multiple myeloma (MM) after therapy. However, current flow-MRD lower sensitivity than molecular methods lacks standardization. Here we report on novel next generation flow (NGF) approach for sensitive standardized MRD detection MM. An optimized 2-tube 8-color antibody panel was constructed five cycles design-evaluation-redesign. In...

10.1038/leu.2017.29 article EN cc-by-nc-nd Leukemia 2017-01-20

Flow cytometric immunophenotyping has become essential for accurate diagnosis, classification, and disease monitoring in hemato-oncology. The EuroFlow Consortium established a fully standardized "all-in-one" pipeline consisting of instrument settings, reagent panels, sample preparation protocols software data analysis classification. For its reproducible implementation, parallel development quality assurance (QA) program was required. Here, we report on the results four consecutive annual...

10.1002/cyto.a.22581 article EN Cytometry Part A 2014-10-23

10.1016/j.diii.2013.04.013 article EN publisher-specific-oa Diagnostic and Interventional Imaging 2013-06-12
Ludovic Lhermitte Sylvain Barreau Daniela Morf Paula Fernández Georgiana Grigore and 95 more Susana Bárrena Maaike de Bie Juan Flores‐Montero Monika Brüggemann Ester Mejstříková Stefan Nierkens Leire Burgos Joana Caetano Giuseppe Gaipa Chiara Buracchi Elaine Sobral da Costa Łukasz Sędek Tomasz Szczepański Carmen-Mariana Aanei Alita van der Sluijs-Gelling Alejandro Hernández-Delgado Rafael Fluxá Quentin Lécrevisse Carlos E. Pedreira Jacques J. M. van Dongen Alberto Órfão Vincent H. J. van der Velden Jacques J. M. van Dongen W. Marieke Bitter Brad Lubbers C.I. Teodosio Mihaela Zlei Alita J. van der Sluijs‐Gelling F. de Bie Sandra de Bruin-Versteeg Mirjam van der Burg Marco W. Schilham Vincent H. J. van der Velden Anton W. Langerak Jeroen te Marvelde A.E. Bras Joyce Schilperoord‐Vermeulen Romana Jugooa Kim C. Heezen Alberto Órfão Júlia Almeida María‐Belén Vidriales Juan Flores‐Montero Martín Pérez‐Andres Sergio Matarraz L. Martín Quentin Lécrevisse J.J. Pérez-Morán N. Puig António Almeida María Gomes da Silva Tiago Faria Monika Brüggemann Matthias Ritgen Monika Szczepanowski Saskia Kohlscheen Anna Laqua E. Harbst Jürgen Finke Vahid Asnafi Ludovic Lhermitte Eugénie Duroyon Jan Trka Ondřej Hrušák Tomáš Kalina Ester Mejstříková Michaela Nováková Daniel Thürner Veronika Kanderová Tomasz Szczepański Łukasz Sędek Joanna Bulsa Łukasz Słota Jan Kulis Carlos E. Pedreira Elaine Sobral da Costa Stefan Nierkens Anneke de Jong Arjan de Koning Margarida Lima Andres Santos Sebastian Böttcher Sandra Lange R. Engelmann Daniel Paape C. Machka Giuseppe Gaipa C. Burracchi Cristina Bugarin Eduardo López‐Granados Lucía del Pino Molina Lydia Campos-Guyotat Carmen Aanei Jesús F. San Miguel Bruno Paiva

Precise classification of acute leukemia (AL) is crucial for adequate treatment. EuroFlow has previously designed an AL orientation tube (ALOT) to guide toward the relevant panel and final diagnosis. In this study, we validated algorithm automated (database-supported) gating identification (AGI tool) cell subsets within samples stained with ALOT. A reference database normal peripheral blood (PB, n = 41) bone marrow (BM; 45) analyzed ALOT was constructed, served as a AGI tool automatically...

10.1038/s41379-020-00677-7 article EN cc-by Modern Pathology 2020-09-30

Abstract Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between mature B-cell neoplasms are lacking. We developed an algorithm-driven classification these lymphomas by flow cytometry and compared it to WHO gold standard diagnosis. Overall, 662 samples from patients representing 9 disease categories were analyzed at laboratories using previously published EuroFlow 5-tube-8-color chronic lymphoproliferative antibody panel. Expression levels of all 26...

10.1182/bloodadvances.2021005725 article EN cc-by-nc-nd Blood Advances 2021-11-24

ABSTRACT CD8 T cells play a major role in antiviral immune responses. Their importance for progression to chronic hepatitis C and response treatment are still unclear. To address these issues, virus (HCV)-specific T-cell responses were monitored, at the single-cell level, using HLA class I pentamers specific HCV core NS3 epitopes, 23 chronically infected patients during with pegylated alpha interferon ribavirin. Patients who presented sustained-response therapy had stronger HCV-specific all...

10.1128/jvi.02175-07 article EN Journal of Virology 2008-05-15

Multiple myeloma (MM), the third most frequent hematological cancer worldwide, is characterized by proliferation of neoplastic plasma cells in bone marrow (BM). One hallmarks MM a permissive BM microenvironment. Increasing evidence suggests that cell-to-cell communication between and immune via tumor cell-derived extracellular vesicles (EV) plays key role pathogenesis MM. Hence, we aimed to explore alterations induced MM-derived EV. For this, inoculated immunocompetent BALB/cByJ mice with...

10.3389/fimmu.2022.909880 article EN cc-by Frontiers in Immunology 2022-07-07

Abstract The synergy resulting from the high conductivity of graphene and catalytic properties metal nanoparticle has been a resource to improve activity functionality electrochemical sensors. This work focuses on simultaneous synthesis copper nanoparticles (CuNPs) laser‐induced (LIG) derived paper, through one‐step laser processing approach. A chromatography paper substrate with drop‐casted sulfate is used for fabrication this hybrid material, characterized in terms its morphological,...

10.1002/adsr.202400052 article EN cc-by Advanced Sensor Research 2024-09-18

Multiple myeloma (MM) is a hematological malignancy of clonal antibody-secreting plasma cells (PCs). MM diagnosis and risk stratification rely on bone marrow (BM) biopsy, an invasive procedure prone to sample bias. Liquid biopsies, such as extracellular vesicles (EV) in peripheral blood (PB), hold promise new minimally tools. Real-world studies analyzing patient-derived EV proteome are rare. Here, we characterized small protein content from PB BM samples cohort 102 monoclonal gammopathies...

10.3389/fonc.2022.860849 article EN cc-by Frontiers in Oncology 2022-06-21

Objective interpretation of FC results may still be hampered by limited technical standardization. The EuroFlow consortium conducted a series experiments to determine the impact different variables on relative distribution and median fluorescence intensity (MFI) markers stained cell populations, from both healthy donors patients' samples with distinct hematological malignancies. use anticoagulants; time interval between sample collection, preparation, acquisition; pH washing buffers; surface...

10.3390/cancers14030473 article EN Cancers 2022-01-18

The introduction of new and more effective therapeutic options for Multiple Myeloma (MM) has significantly deepened prolonged patients’ remission. As currently used treatment protocols induce high rates complete responses, Measurable Residual Disease (MRD) assessment become essential to enhance the evaluation efficacy. Detection MRD improved with development highly sensitive standardized techniques such as Next Generation Flow or Sequencing, complemented by functional imaging techniques....

10.3390/hemato3030027 article EN cc-by Hemato 2022-06-23

<h3>Background:</h3> Nailfold capillaroscopy (PC) is fundamental in the evaluation of RP, helping to differentiate between primary and secondary Raynaud's phenomenon (RP). However, usefulness this technique patients with symptoms suggestive a connective tissue disease (CTD) or positive antibodies, but without has not been established. <h3>Objectives:</h3> To evaluate utility NVC for diagnosis CTD RP. <h3>Methods:</h3> Retrospective review performed RP suspicion CTD, 2010-2022. from an age...

10.1136/annrheumdis-2024-eular.1819 article EN Annals of the Rheumatic Diseases 2024-06-01

Background Multiple myeloma (MM) is an incurable hematologic malignancy, and even though the complete response (CR) rate has been growing, a high percentage of patients continues to relapse. Recent research showed that most relapses may be related persistence measurable residual disease (MRD). In this study, we intended evaluate MRD status in MM who reached CR their second or third lines treatment. Methods This was cross-sectional, multicentre, non-interventional study describe with relapsed...

10.3389/frhem.2024.1480120 article EN cc-by Frontiers in Hematology 2024-12-05

Topic: 13. Myeloma and other monoclonal gammopathies - Biology & Translational Research Background: Multiple (MM) is characterised by the accumulation of plasma cells in a dynamic permissive bone marrow (BM) microenvironment. Most immune express neuronal receptors neurotransmitters, allowing crosstalk between these multicellular networks. Interactions neurons have been reported to regulate organ physiology contribute several cancers. NK are important players MM, adrenergic signals were shown...

10.1097/01.hs9.0000970252.77706.5e article EN cc-by-nc-nd HemaSphere 2023-08-01
Coming Soon ...